𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rituximab treatment in patients with primary Sjögren's syndrome: An open-label phase II study

✍ Scribed by J. Pijpe; G. W. van Imhoff; F. K. L. Spijkervet; J. L. N. Roodenburg; G. J. Wolbink; K. Mansour; A. Vissink; C. G. M. Kallenberg; H. Bootsma


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
204 KB
Volume
52
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


A phase II study of 5-fluorouracil, leuc
✍ Gary R. Hudes; Stuart Lipsitz; Jean Grem; Mary Morrisey; Louis Weiner; John W. K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Chemotherapy has a limited impact on adenocarcinoma of the stomach. Although biochemical modulation of 5-fluorouracil (5-FU) by leucovorin (LV) and interferon-␣ (IFN-␣) has improved the outcomes of patients with metastatic colorectal carcinoma compared with 5-FU alone, this approach has not been ext